Retractable Technologies Inc. - RVP Enterprise Value-to-Revenue Multiple

Retractable Tech (RVP) - corporate logo

Retractable Technologies (RVP) is in a phase of stable post-pandemic demand for medical products, which guarantees a steady cash flow. The company generates revenue through mass supplies of safety syringes for clinics. The consolidated EV/Sales trend on GURU.Markets contains data on the business valuation relative to revenue, where the value -519.37 serves as the current metric. This is critical given the impact of geopolitics on raw material costs and US government contracts.

RVP: Retractable Tech Company Value to Revenue 11/23/2025 - 11/19/2026

RVP (Retractable Technologies, Inc.): analytical breakdowns and indicator data

- market value and analyst target forecast:
Fundamental company valuation:RVP, Retractable Technologies
Original product of retractable.com

The stability of Retractable Technologies (RVP) contracts with the US public sector amid margin pressure from industry behemoths makes the company's EV/Sales ratio a key business valuation indicator, stripped of the influence of debt capital. This metric compares the total enterprise value with actual sales volume, accounting for tax adjustments, which allows investors to assess the premium paid for future growth and the risks associated with a reduction in government subsidies.

Direct competitors

ISRG - EV/Sales Multiple|DHR: EV/Sales Multiple|Enterprise Value-to-Revenue Multiple BD (BDX)|Enterprise Value-to-Revenue Ratio STERIS plc|Company Value to Revenue Ratio WST (West Pharmaceutical Services)|Company Value to Revenue BAX (Baxter Corp)|Masimo - Company Value to Revenue Ratio|Stevanato Group S.p.A. - Company Value to Revenue|Total Company Value-to-Revenue Ratio Teleflex Inc (TFX)|MMSI - Enterprise Value-to-Revenue Ratio|Total Company Value-to-Revenue Ratio Envista Holdings Corp NVST|ICUI: EV/Sales Multiple|Company Value to Revenue Ratio XRAY|LMAT (LeMaitre Corp) - EV/Sales Multiple|ATRC (AtriCure Inc) - Enterprise Value-to-Revenue Coefficient|EV/Sales Multiple STAA|NAGE (ChromaDex Corp) - Business Value to Revenue|ZimVie Inc. - Company Value to Revenue|Total Company Value-to-Revenue Ratio angiodynamics.com (ANGO)|CERS - Enterprise Value-to-Revenue Ratio|TKNO - EV/Sales Multiple|Monogram Technologies Inc (MGRM) - Enterprise Value-to-Revenue Ratio|STSS - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio InfuSystem Holdings, Inc.|Enterprise Value-to-Revenue Multiple Utah Medical Products UTMD|EV/Sales Multiple KRMD|Total Company Value-to-Revenue Ratio Nyxoah, S.A.|Microbot Medical Inc - Company Value to Revenue|Total Company Value-to-Revenue Ratio Pro-Dex Inc. (PDEX)|Zentek - EV/Sales Multiple|Elutia (ELUT) - Company Value to Revenue|Milestone Scientific Inc (MLSS) - Enterprise Value-to-Revenue Ratio|NXGL - Total Company Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio harvardbioscience.com|Femasys Corp (FEMY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple MHUA|Predictive Oncology Inc. - Company Value to Revenue Ratio|EV/Sales Multiple CJMB (Callan JMB Inc)|EV/Sales Multiple Atrion Corp ATRI|NeuroMetrix Corporation - EV/Sales Multiple